Laura Havrilesky
Professor of Obstetrics and GynecologyOverview
I am interested in using health economic models to inform decisions related to gynecologic cancers. Specific models have addressed the decision to administer intraperitoneal chemotherapy for newly diagnosed advanced ovarian cancer following optimal cytoreduction, the choice of chemotherapy regimen for recurrent platinum-sensitive ovarian cancer, and the exploration of screening strategies for ovarian cancer. The ovarian cancer screening model examines the effects of test cost, sensitivity, specificity, and screen frequency on ovarian cancer mortality, the lifetime false positive rate of testing, the positive predictive value of the test, and its cost effectiveness. This type of model is potentially useful in informing the design trials of novel screening tests for ovarian cancer. I am also conducting a prospective study to quantify the effects of screening for, diagnosis of, and treatment for ovarian cancer on the quality of life of women.
Positions
Professor of Obstetrics and Gynecology in the School of Medicine
2014 School of Medicine
Professor in Population Health Sciences in the School of Medicine
2019 School of Medicine
Member of the Duke Cancer Institute in the School of Medicine
1995 School of Medicine
Education
M.D. 1995
1995 Duke University
Residency, Obstetrics and Gynecology
1999 Duke University
Gynecology Oncology Fellowship, OBSTETRICS AND GYNECOLOGY
2002 Duke University, School of Medicine
Clinical Trials
Publications, Grants & Awards
DCI Centers, Cancer Types & Labs
Offices & Contact
Durham, NC
27710 Box 3079 Med Ctr
Durham, NC
27710